[July 01, 2016]

Global Vulvar Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: ISA Pharma, Ono Pharma, PDS Biotechnology Corp - Research and Markets

Research and Markets has announced the addition of the "Vulvar Cancer - Pipeline Review, H1 2016" report to their offering.

The report provides comprehensive information on the therapeutics under development for Vulvar Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vulvar Cancer and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitiv advantage.

Scope:

• The report provides a snapshot of the global therapeutic landscape of Vulvar Cancer
• The report reviews pipeline therapeutics for Vulvar Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Vulvar Cancer therapeutics and enlists all their major and minor projects
• The report assesses Vulvar Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Vulvar Cancer

Companies Mentioned:

• ISA Pharmaceuticals B.V.
• Ono Pharmaceutical Co., Ltd.
• Oryx GmbH & Co. KG
• PDS Biotechnology Corporation

For more information visit http://www.researchandmarkets.com/research/sr3kpv/vulvar_cancer

View source version on businesswire.com: http://www.businesswire.com/news/home/20160701005551/en/

[ Back To TMCnet.com's Homepage ]